tiprankstipranks
Trending News
More News >
Nuo Therapeutics Inc (AURX)
:AURX
US Market
Advertisement

Nuo Therapeutics (AURX) Income Statement

Compare
12 Followers

Nuo Therapeutics Income Statement

Last quarter (Q1 2025), Nuo Therapeutics's total revenue was $484.38K, an increase of 106.49% from the same quarter last year. In Q1, Nuo Therapeutics's net income was $-746.13K. See Nuo Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 1.37M$ 608.52K$ 112.25K$ 0.00$ 0.00
Gross Profit
$ 1.06M$ 482.43K$ 93.04K$ 0.00$ 0.00
Operating Expenses
$ 3.52M$ 3.65M$ 3.41M$ 90.67K$ 378.06K
Depreciation and Amortization
$ 96.27K$ 105.26K$ 74.08K$ 90.67K$ 89.86K
EBITDA
$ -2.36M$ -3.06M$ -3.10M$ 0.00$ -288.20K
Operating Income
$ -2.46M$ -3.17M$ -3.32M$ -90.67K$ -378.06K
Other Income/Expenses
$ 134.13K$ -3.16K$ 148.86K$ 0.00$ 287.19K
Pretax Income
$ -2.32M$ -3.17M$ -3.17M$ -90.67K$ -90.87K
Net Income
$ -2.32M$ -3.17M$ -3.03M$ -90.67K$ -139.26K
Per Share Metrics
Basic EPS
$ -0.05$ -0.08$ -0.08$ 0.00$ -0.01
Diluted EPS
$ -0.05$ -0.08$ -0.08$ 0.00$ -0.01
Weighted Average Shares Outstanding
45.42M 42.08M 40.00M 30.30M 25.69M
Weighted Average Shares Outstanding (Diluted)
45.42M 42.08M 40.00M 30.30M 27.31M
Currency in USD

Nuo Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis